Opiant Pharma (NASDAQ: OPNT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Opiant Pharma (NASDAQ: OPNT) through any online brokerage.
The latest price target for Opiant Pharma (NASDAQ: OPNT) was reported by Oppenheimer on Thursday, December 9, 2021. The analyst firm set a price target for 42.00 expecting OPNT to rise to within 12 months (a possible 251.46% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Opiant Pharma (NASDAQ: OPNT) is $11.95 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Opiant Pharma.
Opiant Pharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Opiant Pharma.
Opiant Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.